|
| Analyst
Scorecard | | Analyst: | Amsellem, David | EPS
Est. Accuracy: | 
| | Broker: | Piper Jaffray | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Pharmaceuticals
|
| Not Avl.
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
ACOR
|
Acorda Therapeutics Inc
| 
|
12
| | | | |
CEPH
|
Cephalon Inc
|
|
22
| | | | |
CYPB
|
Cypress Bioscience Inc
|
|
6
| | | | |
FRX
|
Forest Laboratories Inc
|
|
22
| | | | |
SNTS
|
Santarus Inc
|
|
4
| | | | |
XNPT
|
Xenoport Inc
|
|
16
| | | |
| Other Stocks Covered
| |
Allergan Inc (AGN), Durect Corporation (DRRX), Endo Pharmaceuticals (ENDP), Inspire Pharmaceuticals Inc (ISPH), Medicis Pharmaceutical Corp (MRX), Obagi Medical Products Inc (OMPI), Salix Pharmaceuticals Ltd (SLXP), Valeant Pharma (VRX)
|
| | |
|
|
|
